FRA:RHK • DE0007042301
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for RHOEN-KLINIKUM AG (RHK.DE).
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.446B 3.14% | 1.464B 1.24% | 1.596B 8.99% | 1.678B 5.16% | 1.745B 3.99% | 1.899B 8.83% | 2.026B 6.69% | 2.096B 3.46% | |
| EBITDA YoY % growth | 102.686M 1.64% | 106.664M 3.87% | 111.087M 4.15% | 116.63M 4.99% | 123M 5.46% | 141.4M 14.96% | 152.96M 8.18% | 161.75M 5.75% | |
| EBIT YoY % growth | 33.086M 7.32% | 41.064M 24.11% | 48.487M 18.08% | 49.719M 2.54% | 59.58M 19.83% | 68.68M 15.27% | 78.017M 13.59% | 86.941M 11.44% | |
| Operating Margin | 2.29% | 2.80% | 3.04% | 2.96% | 3.41% | 3.62% | 3.85% | 4.15% | |
| EPS YoY % growth | N/A -27.54% | N/A 76.00% | N/A 40.91% | 0.65 4.30% | 0.76 17.01% | 0.86 12.33% | 0.98 13.60% | 1.08 10.92% |
All data in EUR
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
7 analysts have analysed RHK.DE and the average price target is 14.45 EUR. This implies a price increase of 15.6% is expected in the next year compared to the current price of 12.5.
RHOEN-KLINIKUM AG (RHK.DE) will report earnings on 2026-03-26.
The consensus rating for RHOEN-KLINIKUM AG (RHK.DE) is 74.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.